INTERNATIONAL PATENT: I-MAB BIOPHARMA US LIMITED, ABL BIO INC. FILES APPLICATION FOR "METHODS OF TREATING SOLID TUMORS USING BI-SPECIFIC ANTIBODIES"

GENEVA, March 24 -- I-MAB BIOPHARMA US LIMITED (2440 Research Boulevard, Suite 400Rockville, Maryland 20850), ABL BIO INC. (456, Bongeunsa-ro, Gangnam-guSeoul 06153) filed a patent application (PCT/US2025/046005) for "METHODS OF TREATING SOLID TUMORS USING BI-SPECIFIC ANTIBODIES" on Sep 11, 2025. With publication no. WO/2026/060161, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DENNIS, Phillip A. (c/o I-MAB Biopharma US Limited2440 Research Boulevard, Suite 400Rockville, Maryland 20850), CHUNG, Jou-Ku (c/o I-MAB Biophar...